Oncology

Athletes from a variety of sports dealt with the hardships of diseases treated by specialty pharmacy.

Updated criteria outlined by ASCO may lead to an increase in the number of breast cancers that test HER2-positive.

Top news of the day from across the health care landscape.

Pediatric Hodgkin lymphoma survivors are twice as likely to develop cardiovascular disease.

ASCL1 protein critical in the development of small cell lung cancer.

Olanzapine found to reduce chemotherapy-induced nausea and vomiting in cancer patients.

Researchers found that a majority of patients with cancer had mutations that would affect their treatment.

Certain mutations influence risk of drug resistance across several cancer types.

Keytruda is a humanized monoclonal antibody that increases the ability of the immune system to help detect and fight tumor cells.

Keytruda is a humanized monoclonal antibody that increases the ability of the immune system to help detect and fight tumor cells.

Patients with head and neck carcinoma were more likely to have a better quality-of-life if they had transoral robotic surgery.

Ovarian cancer among the highest death rates for all gynecological cancers.

Damage associated with leukemia occurs in regions where DNA is transcribed actively.

The new technology can separate bioparticles for improved cancer detection.

Study highlights the importance of sunscreen and other protective measures against skin cancer.

Top news of the day from across the health care landscape.

Researchers believe prostate cancer has become more aggressive.

Similarities between laboratory cancer cells and patient tumor samples could create more personalized treatment.

Hormones in body fat provide bridge between breast cancer and obesity.

Patients who relapse following a stem cell transplant for leukemia, lymphoma, or multiple myeloma may benefit from ipilimumab.

Surgery is performed in a different position than pre-operative breast imaging MRIs.

Adcetris is an antibody-drug conjugate that may improve treatment of cutaneous T cell lymphoma.

Meaningful clinical activity found from PD-1 blockade treatment in metastatic prostate cancer patients resistant to androgen deprivation.

Perceived memory problems could be linked to stress rather that treatment in breast cancer survivors.

People with pale skin, freckles, and red hair carry mutations comparable to an extra 21 years of sun exposure.

Approximately 7000 studies involved contaminated HEp-2 and INT 407 cell lines.

Overexpression of Aurora Kinase could potentially inhibit a tumor suppressing gene.

Fluorescence lifetime imaging identifies which breast cancer patients will benefit from specific treatments.